Delivery Order SPE2DB20D3101-SPE2DB23FRWM1
Award Date
9/1/23
Potential Completion Date
9/5/23
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml. The contract has a ceiling value of $3,323.70 and a completion date of January 10, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,570.20 firm fixed price contract is for the supply of the pharmaceutical product Bydureon Bcise 2 mg autoinjector 0.85 mL. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,541.50 firm fixed-price contract is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml to support military healthcare programs. The contract has an ultimate completion date of February 18, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bydureon Bcise 2 mg autoinjectors. The $9,706.56 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 mL. The $1,791.37 fixed-price delivery order contract has a completion date of November 17, 2021 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjectors. The $6,267.96 firm fixed-price contract has a completion date of July 11, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the drug Bydureon BCISE 2 mg autoinjector 0.85 ml. The $9,777.36 firm fixed-price contract has a completion date of March 18, 2022. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to federal healthcare programs, particularly for the Department of Defense and Department of Veterans Affairs. The company holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,390.34 firm-fixed-price contract is for the supply of Bydureon BCISE 2 mg autoinjectors. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,727.44 firm fixed price delivery order contract for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml. The $5,662.56 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, on May 25, 2023, with a completion date of May 26, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...